Govt issues alert on adverse effects of painkiller Meftal
New Delhi: The Indian Pharmacopoeia Commission (IPC) has issued a cautionary notice regarding the safety of the pain reliever Meftal, commonly used for menstrual cramps and rheumatoid arthritis, according to a report in the media.
The advisory asks healthcare professionals and patients to actively monitor for any negative reactions associated with the drug.
Meftal, which contains mefenamic acid, is prescribed for conditions such as rheumatoid arthritis, osteoarthritis, dysmenorrhoea, mild to moderate pain, inflammation, fever, and dental pain.
In the alert, the commission highlighted a preliminary examination of adverse drug reactions documented in the Pharmacovigilance Programme of India (PvPI) database, revealing instances of drug reactions linked to eosinophilia and systemic symptoms (DRESS) syndrome, the report said.
In case of encountering such reactions, the advisory recommends reporting the issue to the national coordination center of the Pharmacovigilance Programme of India (PvPI) through the commission's website, www.ipc.gov.in, or using the Android mobile apps ADR PvPI, it added.
Alternatively, individuals can contact the PvPI Helpline at 1800-180-3024.
The IPC functions as an independent body under the Ministry of Health. It plays a crucial role in establishing standards for the manufacturing, sale, and consumption of all drugs in India.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles
UN issues dire warning: Asia faces rising cyclones and flooding like never before
Across southeast Asia, record-breaking rains and flooding caused by back-to-back tropical storms have claimed hundreds of lives and brought devastation and displacement upon entire communities, UN agencies said on Tuesday.
Hidden mental health cost of birth control pills? Study finds shocking link
A new study has suggested that the use of contraceptive pills may have a hidden cost: impaired mental health.
Stunning drop! India reports 49% fall in annual new HIV cases
The Indian government has announced that the country recorded a nearly 49 per cent decline in annual new HIV infections between 2010 and 2024.
WHO describes obesity as a 'chronic disease', backs wider use of weight-loss medicines
The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant shift in global health policy as obesity rates continue to rise.
Latest News
Mosque in the middle of Kolkata airport? Centre confirms flight risks, BJP fires at Mamata
Prime Minister Mark Carney to attend FIFA World Cup 2026 Final Draw in Washington
Germany arrests two Iraqi nationals over suspected Islamic State links
Spanish tourist stabbed at Berlin Holocaust Memorial testifies in terror trial
